CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Testosterone for Depression, PTSD, or Fibromyalgia: Clinical Effectiveness and Guidelines

Last updated: February 9, 2017
Project Number: RA0892-000
Product Line: Rapid Response
Research Type: Drug
Report Type: Reference List
Result type: Report

Question

  1. What is the clinical effectiveness of testosterone for patients with depression?
  2. What is the clinical effectiveness of testosterone for patients with post-traumatic stress disorder?
  3. What is the clinical effectiveness of testosterone for patients with fibromyalgia?
  4. What are the evidence-based guidelines for the use of testosterone for patients with depression, PTSD, or fibromyalgia?

Key Message

Two systematic reviews, two randomized controlled trials, six non-randomized studies, and two evidence-based guidelines were identified regarding the clinical effectiveness of testosterone for patients with depression.